Predictors and Clinical Outcomes of Poor Platelet Recovery in Adult Dengue With Thrombocytopenia: A Multicenter, Prospective Study.


Journal

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213

Informations de publication

Date de publication:
11 07 2020
Historique:
received: 01 05 2019
accepted: 15 09 2019
pubmed: 19 10 2019
medline: 13 3 2021
entrez: 19 10 2019
Statut: ppublish

Résumé

Platelet transfusion is common in dengue patients with thrombocytopenia. We previously showed in a randomized clinical trial that prophylactic platelet transfusion did not reduce clinical bleeding. In this study, we aimed to characterize the predictors and clinical outcomes of poor platelet recovery in transfused and nontransfused participants. We analyzed patients from the Adult Dengue Platelet Study with laboratory-confirmed dengue with ≤20 000 platelets/μL and without persistent mild bleeding or any severe bleeding in a post hoc analysis. Poor platelet recovery was defined as a platelet count of ≤20 000/μL on Day 2. We recruited 372 participants from 5 acute care hospitals located in Singapore and Malaysia between 29 April 2010 and 9 December 2014. Of these, 188 were randomly assigned to the transfusion group and 184 to the control group. Of 360 patients, 158 had poor platelet recovery. Age, white cell count, and day of illness at study enrollment were significant predictors of poor platelet recovery after adjustment for baseline characteristics and platelet transfusion. Patients with poor platelet recovery had longer hospitalizations but no significant difference in other clinical outcomes, regardless of transfusion. We found a significant interaction between platelet recovery and transfusion; patients with poor platelet recovery were more likely to bleed if given a prophylactic platelet transfusion (odds ratio 2.34, 95% confidence interval 1.18-4.63). Dengue patients with thrombocytopenia who were older or presented earlier and with lower white cell counts were more likely to have poor platelet recovery. In patients with poor platelet recovery, platelet transfusion does not improve outcomes and may actually increase the risk of bleeding. The mechanisms of poor platelet recovery need to be determined. NCT01030211.

Sections du résumé

BACKGROUND
Platelet transfusion is common in dengue patients with thrombocytopenia. We previously showed in a randomized clinical trial that prophylactic platelet transfusion did not reduce clinical bleeding. In this study, we aimed to characterize the predictors and clinical outcomes of poor platelet recovery in transfused and nontransfused participants.
METHODS
We analyzed patients from the Adult Dengue Platelet Study with laboratory-confirmed dengue with ≤20 000 platelets/μL and without persistent mild bleeding or any severe bleeding in a post hoc analysis. Poor platelet recovery was defined as a platelet count of ≤20 000/μL on Day 2. We recruited 372 participants from 5 acute care hospitals located in Singapore and Malaysia between 29 April 2010 and 9 December 2014. Of these, 188 were randomly assigned to the transfusion group and 184 to the control group.
RESULTS
Of 360 patients, 158 had poor platelet recovery. Age, white cell count, and day of illness at study enrollment were significant predictors of poor platelet recovery after adjustment for baseline characteristics and platelet transfusion. Patients with poor platelet recovery had longer hospitalizations but no significant difference in other clinical outcomes, regardless of transfusion. We found a significant interaction between platelet recovery and transfusion; patients with poor platelet recovery were more likely to bleed if given a prophylactic platelet transfusion (odds ratio 2.34, 95% confidence interval 1.18-4.63).
CONCLUSIONS
Dengue patients with thrombocytopenia who were older or presented earlier and with lower white cell counts were more likely to have poor platelet recovery. In patients with poor platelet recovery, platelet transfusion does not improve outcomes and may actually increase the risk of bleeding. The mechanisms of poor platelet recovery need to be determined.
CLINICAL TRIALS REGISTRATION
NCT01030211.

Identifiants

pubmed: 31626692
pii: 5598980
doi: 10.1093/cid/ciz850
doi:

Banques de données

ClinicalTrials.gov
['NCT01030211']

Types de publication

Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

383-389

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Auteurs

Sophia Archuleta (S)

Division of Infectious Diseases, National University Hospital, National University Health System, Singapore.
Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.

Po Ying Chia (PY)

Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore.
National Centre for Infectious Diseases, Singapore.
Lee Kong Chian School of Medicine, Singapore.

Yuan Wei (Y)

Singapore Clinical Research Institute, Singapore.

Sharifah F Syed-Omar (SF)

University Malaya Medical Centre, Kuala Lumpur, Malaysia.

Jenny G Low (JG)

Singapore General Hospital, Singapore.
Duke-NUS Graduate Medical School, Singapore.

Helen M Oh (HM)

Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Changi General Hospital, Singapore; and.

Dale Fisher (D)

Division of Infectious Diseases, National University Hospital, National University Health System, Singapore.
Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.

Sasheela S L Ponnampalavanar (SSL)

University Malaya Medical Centre, Kuala Lumpur, Malaysia.

Limin Wijaya (L)

Singapore General Hospital, Singapore.

Adeeba Kamarulzaman (A)

University Malaya Medical Centre, Kuala Lumpur, Malaysia.

Lucy C S Lum (LCS)

University Malaya Medical Centre, Kuala Lumpur, Malaysia.

Paul A Tambyah (PA)

Division of Infectious Diseases, National University Hospital, National University Health System, Singapore.
Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.

Yee-Sin Leo (YS)

Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore.
National Centre for Infectious Diseases, Singapore.
Lee Kong Chian School of Medicine, Singapore.
Saw Swee Hock School of Public Health, National University of Singapore, Singapore.

David C Lye (DC)

Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore.
National Centre for Infectious Diseases, Singapore.
Lee Kong Chian School of Medicine, Singapore.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH